Testosterone After 35: What's Normal, What's Optimal, and What's the Difference

The "Normal" Problem

Every year, millions of men in their 30s, 40s, and 50s visit their primary care physician complaining of fatigue, low libido, difficulty building muscle, brain fog, and a general sense that something is off. They get a testosterone test. The result comes back at 380 ng/dL. The doctor says: "You're in the normal range." The man goes home feeling dismissed — and continues to feel terrible.

This scenario plays out thousands of times a day across the country, and it represents one of the most significant failures of conventional medicine's approach to men's health. The problem is not the test — it's the reference range.

Standard laboratory reference ranges for total testosterone typically span from approximately 300 to 1,000 ng/dL. These ranges are derived from population averages that include men of all ages, health statuses, and body compositions — including men in their 70s and 80s with multiple chronic diseases. A 42-year-old man with a testosterone level of 320 ng/dL is technically "normal" by these standards. But he is functioning at the hormonal level of a man 30 years his senior.

Normal vs. Optimal: Understanding the Gap

In precision medicine, we distinguish between two very different concepts: normal and optimal. Normal means you fall within the statistical distribution of the general population. Optimal means your levels are in the range associated with peak function, health, and longevity.

For testosterone, optimal levels in men are generally considered to be in the range of 700–1,000 ng/dL total testosterone, with free testosterone in the upper quartile of the reference range. This is the range associated with:

• Maximum lean muscle mass and metabolic rate
• Optimal cognitive function, focus, and executive performance
• Cardiovascular protection (testosterone is anti-atherogenic at physiological levels)
• Bone mineral density preservation
• Healthy libido and sexual function
• Mood stability, motivation, and resilience to stress
• Reduced risk of metabolic syndrome and type 2 diabetes

A man with a testosterone level of 380 ng/dL is not experiencing any of these benefits. He is, in the clinical sense, testosterone-deficient — regardless of what the reference range says.

The Decline Trajectory: What Happens After 30

Testosterone production peaks in the late teens and early 20s, then begins a gradual but relentless decline. The average rate of decline is approximately 1–2% per year after age 30 — meaning that by age 50, most men have lost 20–40% of their peak testosterone production. By age 60, the average man has testosterone levels roughly equivalent to a prepubertal boy.

This decline is not inevitable in the sense that it cannot be modified — but it is universal in the sense that it affects virtually all men to some degree. The rate of decline is significantly accelerated by:

Beyond Total Testosterone: The Complete Hormonal Picture

One of the most common mistakes in testosterone assessment — even among physicians who take the issue seriously — is focusing exclusively on total testosterone. Total testosterone measures the sum of all testosterone in the bloodstream, including testosterone bound to sex hormone-binding globulin (SHBG) and albumin. But only free testosterone — the fraction not bound to SHBG — is biologically active and able to enter cells and exert its effects.

A man with a total testosterone of 650 ng/dL but elevated SHBG may have free testosterone levels equivalent to a man with a total of 350 ng/dL — and experience all the symptoms of deficiency. Conversely, a man with a total of 450 ng/dL but low SHBG may have adequate free testosterone and feel completely well.

A complete testosterone assessment at SummaUp includes:

• Total testosterone — The starting point, but not the complete picture
• Free testosterone (calculated and direct) — The biologically active fraction
• SHBG (sex hormone-binding globulin) — Determines how much testosterone is bioavailable
• Estradiol (E2) — Testosterone converts to estradiol via aromatase; elevated E2 causes symptoms even with adequate T
• LH and FSH — Distinguish primary (testicular) from secondary (pituitary) hypogonadism
• Prolactin — Elevated prolactin suppresses LH and testosterone production
• DHT (dihydrotestosterone) — The potent androgen responsible for libido, hair, and prostate effects
• DHEA-S — Adrenal androgen precursor that declines with age and contributes to overall androgen status

Testosterone Replacement Therapy: What the Evidence Actually Shows

Testosterone replacement therapy (TRT) has been the subject of significant controversy — much of it driven by misinterpretation of early studies and conflation of supraphysiological (anabolic steroid) doses with physiological replacement therapy. The evidence for well-managed TRT at physiological doses is, in fact, quite robust.

The landmark Testosterone Trials (TTrials) — a coordinated set of seven placebo-controlled trials conducted at 12 academic medical centers — demonstrated that testosterone therapy in men with low testosterone produced significant improvements in:

The cardiovascular finding from the TTrials was initially concerning, but subsequent research — including the large TRAVERSE trial (2023), the largest randomized controlled trial of TRT ever conducted — found that testosterone therapy did not increase the risk of major adverse cardiovascular events (MACE) in men with hypogonadism and established cardiovascular disease or high cardiovascular risk. In fact, emerging evidence suggests that testosterone deficiency itself is a cardiovascular risk factor, and that restoring physiological levels may be cardioprotective.

The SummaUp Testosterone Optimization Protocol

At SummaUp, testosterone optimization is never a one-size-fits-all prescription. Dr. Ryan Das designs each protocol based on the individual's complete hormonal profile, symptoms, health history, and goals — with the aim of restoring testosterone to the upper quartile of youthful physiological ranges while maintaining hormonal balance across the entire endocrine system.

Our approach integrates multiple modalities:

Key Takeaways

• Standard laboratory reference ranges for testosterone are calibrated to population averages — not optimal function. A level of 300–400 ng/dL may be "normal" but represents significant deficiency for most men under 50.
• Free testosterone — not total testosterone — is the biologically active fraction. SHBG, estradiol, LH, FSH, and prolactin must all be assessed for a complete hormonal picture.
• Testosterone declines 1–2% per year after age 30, accelerated by chronic stress, poor sleep, visceral fat, sedentary lifestyle, and environmental toxins.
• The TRAVERSE trial (2023) — the largest RCT of TRT ever conducted — found no increased risk of major cardiovascular events with testosterone therapy in men with hypogonadism.
• Optimal testosterone levels (700–1,000 ng/dL) are associated with lean body composition, cognitive performance, cardiovascular protection, bone density, and longevity.